113 related articles for article (PubMed ID: 38336502)
1. Clinical and neuroimaging association between neuropsychiatric symptoms and nutritional status across the Alzheimer's disease continuum: a longitudinal cohort study.
Jiang J; Wang A; Shi H; Jiang S; Li W; Jiang T; Wang L; Zhang X; Sun M; Zhao M; Zou X; Xu J
J Nutr Health Aging; 2024 Mar; 28(3):100182. PubMed ID: 38336502
[TBL] [Abstract][Full Text] [Related]
2. Malnutrition and neuropsychiatric symptoms in dementia: the Cache County Dementia Progression Study.
Kauzor K; Drewel M; Gonzalez H; Rattinger GB; Hammond AG; Wengreen H; Lyketsos CG; Tschanz JT
Int Psychogeriatr; 2023 Nov; 35(11):653-663. PubMed ID: 37246509
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal association between nutritional status and behavioral and psychological symptoms of dementia in older women with mild cognitive impairment and early-stage Alzheimer's disease.
Kishino Y; Sugimoto T; Kimura A; Kuroda Y; Uchida K; Matsumoto N; Saji N; Niida S; Sakurai T
Clin Nutr; 2022 Sep; 41(9):1906-1912. PubMed ID: 35947893
[TBL] [Abstract][Full Text] [Related]
5. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
Burhanullah MH; Tschanz JT; Peters ME; Leoutsakos JM; Matyi J; Lyketsos CG; Nowrangi MA; Rosenberg PB
Am J Geriatr Psychiatry; 2020 Jan; 28(1):64-71. PubMed ID: 31186157
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
M FM; Molano A; Castro J; Zarranz JJ
Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
[TBL] [Abstract][Full Text] [Related]
8. Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
Cannizzaro A; Ronat L; El Haffaf LM; Hanganu A;
Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5952. PubMed ID: 37351584
[TBL] [Abstract][Full Text] [Related]
9. Malnutrition is Associated with Behavioral and Psychiatric Symptoms of Dementia in Older Women with Mild Cognitive Impairment and Early-Stage Alzheimer's Disease.
Kimura A; Sugimoto T; Kitamori K; Saji N; Niida S; Toba K; Sakurai T
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31434232
[TBL] [Abstract][Full Text] [Related]
10. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
[TBL] [Abstract][Full Text] [Related]
11. Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
Jiang J; Hong Y; Li W; Wang A; Jiang S; Jiang T; Wang Y; Wang L; Yang S; Ren Q; Zou X; Xu J
J Alzheimers Dis; 2023; 96(2):669-681. PubMed ID: 37840496
[TBL] [Abstract][Full Text] [Related]
12. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
Vik-Mo AO; Giil LM; Ballard C; Aarsland D
Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.
Poulin SP; Bergeron D; Dickerson BC;
J Alzheimers Dis; 2017; 60(2):483-493. PubMed ID: 28869463
[TBL] [Abstract][Full Text] [Related]
14. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
15. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
[TBL] [Abstract][Full Text] [Related]
17. Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).
Guerin O; Soto ME; Brocker P; Robert PH; Benoit M; Vellas B;
J Nutr Health Aging; 2005; 9(2):81-4. PubMed ID: 15791350
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
